Eric J. Niesor

2.4k total citations
67 papers, 1.8k citations indexed

About

Eric J. Niesor is a scholar working on Surgery, Cancer Research and Molecular Biology. According to data from OpenAlex, Eric J. Niesor has authored 67 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Surgery, 26 papers in Cancer Research and 23 papers in Molecular Biology. Recurrent topics in Eric J. Niesor's work include Cholesterol and Lipid Metabolism (25 papers), Cancer, Lipids, and Metabolism (25 papers) and Lipoproteins and Cardiovascular Health (22 papers). Eric J. Niesor is often cited by papers focused on Cholesterol and Lipid Metabolism (25 papers), Cancer, Lipids, and Metabolism (25 papers) and Lipoproteins and Cardiovascular Health (22 papers). Eric J. Niesor collaborates with scholars based in Switzerland, United States and United Kingdom. Eric J. Niesor's co-authors include C. Bentzen, Anne Perez, David Kallend, Cyrille Maugeais, Liliane Michalik, Jennifer Rieusset, Béatrice Desvergne, Walter Wahli, Pascal Escher and Renée Benghozi and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Eric J. Niesor

64 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric J. Niesor Switzerland 24 905 683 546 391 361 67 1.8k
Elaine Quinet United States 27 1.3k 1.5× 894 1.3× 610 1.1× 520 1.3× 427 1.2× 37 2.2k
Larbi Krimbou Canada 28 1.3k 1.4× 769 1.1× 666 1.2× 434 1.1× 331 0.9× 36 1.8k
T J van Berkel Netherlands 27 786 0.9× 872 1.3× 345 0.6× 310 0.8× 404 1.1× 48 2.3k
Ginny Kellner-Weibel United States 15 1.5k 1.6× 876 1.3× 549 1.0× 412 1.1× 401 1.1× 20 2.1k
Annie St‐Pierre Canada 12 451 0.5× 510 0.7× 486 0.9× 353 0.9× 184 0.5× 22 1.4k
Roberta Baetta Italy 22 944 1.0× 621 0.9× 300 0.5× 304 0.8× 358 1.0× 39 2.1k
V. Atger France 25 1.2k 1.3× 600 0.9× 724 1.3× 216 0.6× 329 0.9× 44 2.0k
Guoqing Cao China 26 2.1k 2.3× 702 1.0× 374 0.7× 364 0.9× 303 0.8× 75 2.9k
Daniel L. Sparks Canada 28 1.0k 1.1× 864 1.3× 975 1.8× 144 0.4× 301 0.8× 62 2.1k
M J Bamberger United States 19 1.2k 1.3× 643 0.9× 756 1.4× 196 0.5× 370 1.0× 24 1.8k

Countries citing papers authored by Eric J. Niesor

Since Specialization
Citations

This map shows the geographic impact of Eric J. Niesor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric J. Niesor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric J. Niesor more than expected).

Fields of papers citing papers by Eric J. Niesor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric J. Niesor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric J. Niesor. The network helps show where Eric J. Niesor may publish in the future.

Co-authorship network of co-authors of Eric J. Niesor

This figure shows the co-authorship network connecting the top 25 collaborators of Eric J. Niesor. A scholar is included among the top collaborators of Eric J. Niesor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric J. Niesor. Eric J. Niesor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Niesor, Eric J., et al.. (2025). Low-dose obicetrapib significantly increases concentrations of lipophilic antioxidants, APOE, and S1P in HDL subfractions. Atherosclerosis. 407. 119512–119512. 1 indexed citations
3.
Brodeur, Mathieu R., David Rhainds, Eric J. Niesor, et al.. (2022). Dalcetrapib and anacetrapib increase apolipoprotein E-containing HDL in rabbits and humans. Journal of Lipid Research. 64(1). 100316–100316. 1 indexed citations
4.
Niesor, Eric J., Guy Boivin, Éric Rhéaume, et al.. (2021). Inhibition of the 3CL Protease and SARS-CoV-2 Replication by Dalcetrapib. ACS Omega. 6(25). 16584–16591. 18 indexed citations
5.
Brodeur, Mathieu R., David Rhainds, Evelyne Chaput, et al.. (2017). Dalcetrapib and anacetrapib differently impact HDL structure and function in rabbits and monkeys. Journal of Lipid Research. 58(7). 1282–1291. 12 indexed citations
6.
Rosenson, Robert S., H. Bryan Brewer, Philip J. Barter, et al.. (2017). HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology. Nature Reviews Cardiology. 15(1). 9–19. 93 indexed citations
7.
Ballantyne, Christie M., Michael Miller, Eric J. Niesor, et al.. (2012). Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: Results of a phase IIb dose-ranging study. American Heart Journal. 163(3). 515–521.e3. 49 indexed citations
8.
Ballantyne, Christie M., Michael R. Miller, Eric J. Niesor, et al.. (2010). EFFECT OF DALCETRAPIB PLUS PRAVASTATIN ON LIPOPROTEIN METABOLISM IN DYSLIPIDEMIC PATIENTS: RESULTS OF A PHASE 2B DOSE-RANGING STUDY. Journal of the American College of Cardiology. 55(10). A47.E444–A47.E444. 1 indexed citations
9.
Clerc, Roger G., Anne Perez, Jean-Christophe Hoflack, et al.. (2010). Mechanisms underlying off-target effects of the cholesteryl ester transfer protein inhibitor torcetrapib involve L-type calcium channels. Journal of Hypertension. 28(8). 1676–1686. 46 indexed citations
10.
Niesor, Eric J., Christine Magg, Naoto Ogawa, et al.. (2010). Modulating cholesteryl ester transfer protein activity maintains efficient pre-β-HDL formation and increases reverse cholesterol transport. Journal of Lipid Research. 51(12). 3443–3454. 128 indexed citations
11.
Maugeais, Cyrille, Christine Magg, Gregor Dernick, et al.. (2009). Abstract 1092: Dalcetrapib Binds to and Changes the Conformation of CETP in a Unique Manner (Differing to That Observed With Torcetrapib). Circulation. 120(3). 229–38. 3 indexed citations
12.
Niesor, Eric J., Hiroshi Okamoto, Cyrille Maugeais, et al.. (2009). Abstract 1271: The Effects of Dalcetrapib on Macrophage Reverse Cholesterol Transport in a Rodent Model. Circulation. 120. 3 indexed citations
13.
Kastelein, John J.P., Agnès Bénardeau, Olaf Kuhlmann, et al.. (2009). Dalcetrapib: no off‐target toxicity on blood pressure or on genes related to the renin‐angiotensin‐aldosterone system in rats. British Journal of Pharmacology. 158(7). 1763–1770. 39 indexed citations
14.
Capponi, Alessandro M., Roger G. Clerc, Luciana Aparecida Campos, et al.. (2008). Abstract 3618: No Increase in the In Vitro Production of Aldosterone or the Expression of CYP11B2 with the CETP Modulator Dalcetrapib (RO4607381/JTT-705), in Contrast with Torcetrapib. Circulation. 118. 6 indexed citations
15.
Edwards, Claire M., Anke J. Roelofs, Andrew Chantry, et al.. (2007). Apomine™, an inhibitor of HMG‐CoA‐reductase, promotes apoptosis of myeloma cellsin vitroand is associated with a modulation of myelomain vivo. International Journal of Cancer. 120(8). 1657–1663. 17 indexed citations
16.
17.
Rieusset, Jennifer, Liliane Michalik, Pascal Escher, et al.. (2002). A New Selective Peroxisome Proliferator-Activated Receptor γ Antagonist with Antiobesity and Antidiabetic Activity. Molecular Endocrinology. 16(11). 2628–2644. 191 indexed citations
18.
Alberts, David S., Alton V. Hallum, Dava J. Garcia, et al.. (2001). Phase I pharmacokinetic trial and correlative in vitro phase II tumor kinetic study of Apomine (SR-45023A), a novel oral biphosphonate anticancer drug.. PubMed. 7(5). 1246–50. 28 indexed citations
19.
Flach, Jean, et al.. (2000). The Mevalonate/Isoprenoid Pathway Inhibitor Apomine (SR-45023A) Is Antiproliferative and Induces Apoptosis Similar to Farnesol. Biochemical and Biophysical Research Communications. 270(1). 240–246. 26 indexed citations
20.
Maechler, Pierre, Claes B. Wollheim, C. Bentzen, & Eric J. Niesor. (1993). Importance of Exogenous Cholesterol in Diabetic Rats: Effects of Treatment with Insulin or with an Acyl-CoA:Cholesterol Acyltransferase Inhibitor. Annals of Nutrition and Metabolism. 37(4). 199–209. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elaine Quinet Breakdown of academic impact, for papers by Larbi Krimbou Breakdown of academic impact, for papers by T J van Berkel Breakdown of academic impact, for papers by Ginny Kellner-Weibel Breakdown of academic impact, for papers by Annie St‐Pierre Breakdown of academic impact, for papers by Roberta Baetta Breakdown of academic impact, for papers by V. Atger Breakdown of academic impact, for papers by Guoqing Cao Breakdown of academic impact, for papers by Daniel L. Sparks Breakdown of academic impact, for papers by M J Bamberger
Rankless by CCL
2026